Mounjaro UK NHS Side Effects: Complete Safety Guide

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro UK NHS Side Effects - Price £124.99

Understand Mounjaro side effects at the cheapest UK price from £124.99 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Mounjaro UK NHS Side Effects: Complete Safety Guide

Published on: June 03, 2026

Understanding mounjaro uk nhs side effects is essential before starting treatment with tirzepatide. As UK pharmacists who have supported thousands of patients through their weight loss journey, we've compiled this comprehensive guide based on clinical trial data, MHRA guidance, and real-world patient experiences to help you navigate Mounjaro safely and effectively.

Common Mounjaro Side Effects: What Clinical Trials Show

In the landmark SURPASS clinical trial programme, gastrointestinal side effects were the most frequently reported adverse events with tirzepatide [1]. Nausea affected approximately 20-30% of participants, whilst diarrhoea occurred in 15-23% and vomiting in 8-13%, with rates varying by dose strength [1]. These figures align closely with NHS England guidance on GLP-1 receptor agonist safety profiles.

The majority of gastrointestinal symptoms were mild to moderate in severity and typically emerged during dose escalation phases [1]. Importantly, over 90% of participants who experienced nausea reported improvement within 4-8 weeks as their bodies adapted to the medication. Only 4-7% of trial participants discontinued Mounjaro due to gastrointestinal side effects, significantly lower than many other weight loss interventions [2].

Beyond digestive symptoms, clinical trials documented decreased appetite in 5-10% of patients, injection site reactions in 3-5%, and fatigue in 2-4% of participants [1]. These effects were generally transient and resolved without medical intervention. Understanding this timeline helps patients distinguish between expected adjustment periods and genuine concerns requiring clinical review.

Frequency and Severity Grading

The MHRA classifies Mounjaro side effects using standardised frequency categories: very common (affecting more than 1 in 10 people), common (1 in 10 to 1 in 100), and uncommon (1 in 100 to 1 in 1,000). Nausea and diarrhoea fall into the 'very common' category, whilst constipation and abdominal pain are classified as 'common' [3]. This grading system, used across NHS prescribing, helps patients contextualise their individual experiences against population-level data.

Managing Nausea and Digestive Symptoms on Mounjaro

Evidence-based strategies can significantly reduce the impact of gastrointestinal side effects. Eating smaller, more frequent meals throughout the day rather than three large portions helps minimise stomach distension and reduces nausea triggers. Avoiding high-fat, spicy, or heavily processed foods during the first 48 hours after each injection can also decrease symptom severity, as these foods slow gastric emptying—an effect already enhanced by tirzepatide's mechanism of action [2].

Hydration plays a crucial role in managing diarrhoea and preventing the rare but serious risk of dehydration. NHS guidance recommends consuming at least 2 litres of water daily, with additional fluids if diarrhoea persists beyond 24 hours. Ginger tea, consumed 30 minutes before meals, has shown benefit in clinical practice for nausea management, though it hasn't been formally studied in tirzepatide trials.

Timing your injection can make a meaningful difference. Many patients find that administering Mounjaro in the evening, after their main meal, reduces next-day nausea compared to morning injections. If symptoms persist beyond 8 weeks or significantly impact your quality of life, your prescriber may recommend temporarily maintaining your current dose rather than escalating, allowing additional adaptation time before increasing to the next strength.

Serious Side Effects: Recognition and Response

Whilst uncommon, pancreatitis represents the most serious potential adverse effect associated with GLP-1 receptor agonists including Mounjaro. In the SURPASS trials, acute pancreatitis occurred in approximately 0.2% of tirzepatide-treated participants compared to 0.1% in placebo groups [1]. Symptoms include severe, persistent abdominal pain radiating to the back, nausea with repeated vomiting, and abdominal tenderness. If you experience these symptoms, stop Mounjaro immediately and seek urgent medical attention through NHS 111 or your local A&E department.

Gallbladder disorders, including cholecystitis and cholelithiasis, occurred in 1.5-2.5% of trial participants, likely related to rapid weight loss rather than direct medication effects [2]. Warning signs include sudden pain in the upper right abdomen, particularly after fatty meals, accompanied by nausea or fever. Your GP can arrange an ultrasound scan if gallbladder disease is suspected.

Hypoglycaemia (low blood sugar) is uncommon with Mounjaro monotherapy but increases if you're also taking insulin or sulfonylureas. Symptoms include shakiness, sweating, confusion, and rapid heartbeat. The MHRA recommends that patients on combination therapy monitor blood glucose levels regularly and work with their prescriber to adjust doses of concurrent diabetes medications [3]. Severe allergic reactions (anaphylaxis) are extremely rare but require immediate emergency care if you develop facial swelling, difficulty breathing, or widespread rash after injection.

When to Contact Your Prescriber

Contact your UK prescriber if you experience persistent vomiting lasting more than 24 hours, signs of dehydration (dark urine, dizziness, decreased urination), severe abdominal pain, visual changes, or unexplained lumps in your neck area. At Cured Pharmacy, our clinical team led by superintendent pharmacist Tarun Kumar (GPhC 2233073) provides ongoing support throughout your treatment journey, with accessible advice channels for any side effect concerns.

Treatment Most Common Side Effects Frequency of Nausea Starting Price
Mounjaro (tirzepatide) Nausea, diarrhoea, decreased appetite 20-30% From £124.99
Wegovy (semaglutide) Nausea, diarrhoea, vomiting 20-44% From £69.00
Saxenda (liraglutide) Nausea, diarrhoea, constipation 18-39% From £68.00
Orlistat Oily stools, faecal urgency, flatulence Rare From £32.00
Xenical (orlistat 120mg) Oily stools, faecal urgency, abdominal pain Rare From £32.00

Mounjaro Side Effects Compared to Other Weight Loss Treatments

Understanding how Mounjaro's side effect profile compares to alternatives helps inform treatment decisions. Semaglutide-based treatments like Wegovy show similar gastrointestinal side effect rates, with nausea affecting 20-44% of participants in STEP trials and typically resolving within 4-8 weeks [4]. The dual GIP/GLP-1 mechanism of tirzepatide may offer advantages in tolerability for some patients, though individual responses vary significantly.

Liraglutide (Saxenda), requiring daily injections, demonstrated comparable nausea rates but higher discontinuation due to injection fatigue in long-term studies. Orlistat-based treatments like Xenical produce different side effects entirely—primarily gastrointestinal effects related to fat malabsorption rather than appetite regulation, including oily stools and faecal urgency in up to 20% of users.

The key distinction lies in Mounjaro's efficacy-to-side-effect ratio. Whilst gastrointestinal symptoms occur frequently, the average 22.5% body weight reduction achieved in SURPASS-3 trials represents substantially greater weight loss than comparator treatments, with only marginally higher side effect rates [1]. This favourable balance has influenced NICE evaluation processes and NHS England commissioning decisions for tier 3 weight management services.

Long-Term Safety Profile and Ongoing Monitoring

Extended follow-up data from the SURPASS programme now spans up to 104 weeks, providing reassurance about Mounjaro's long-term safety profile [1]. Gastrointestinal side effects typically diminish significantly after the initial 12-16 week titration period, with fewer than 5% of patients experiencing persistent nausea beyond 6 months of stable-dose therapy. Cardiovascular safety analyses showed no increased risk of major adverse cardiac events, an important consideration given the cardiovascular comorbidities often present in patients with obesity.

The MHRA requires ongoing pharmacovigilance for all GLP-1 receptor agonists, with particular attention to thyroid disorders and renal function. Whilst animal studies identified thyroid C-cell tumours at extremely high doses, no causal link has been established in human trials to date [3]. Nevertheless, Mounjaro remains contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Regular clinical monitoring supports safe long-term use. NHS guidance recommends baseline assessment of renal function, with repeat testing if you develop persistent vomiting or diarrhoea that could affect kidney function. Patients with pre-existing kidney disease require closer monitoring during dose escalation. Your prescriber should review treatment efficacy and tolerability at 3-6 month intervals, assessing whether continued therapy remains clinically appropriate based on weight loss response and side effect burden.

Medication Interactions and Contraindications

Mounjaro slows gastric emptying, potentially affecting absorption of oral medications. If you take levothyroxine for thyroid conditions, separate administration by at least 4 hours from your Mounjaro injection. Oral contraceptives may have reduced efficacy during the first 4 weeks after starting or increasing Mounjaro doses—use additional barrier contraception during this period. Always inform your prescriber of all medications, including over-the-counter products and supplements, before starting tirzepatide therapy [3].

Accessing Mounjaro Safely Through UK Pharmacy Services

All Mounjaro prescriptions in the UK must follow MHRA regulations requiring clinical assessment by a registered prescriber. At Cured Pharmacy (GPhC registration 9012511), our online consultation process takes under 3 minutes and is reviewed by UK-registered clinicians who assess your medical history, current medications, and suitability for tirzepatide therapy. This ensures appropriate patient selection and minimises preventable adverse effects.

Genuine UK-licensed Mounjaro KwikPens are available from £124.99, with transparent upfront pricing before consultation. We supply only MHRA-approved medications sourced through legitimate UK pharmaceutical supply chains, eliminating risks associated with counterfeit or unlicensed products that may contain incorrect doses or contaminants. Each prescription includes comprehensive patient information leaflets detailing side effects, administration technique, and emergency guidance.

Our clinical team provides ongoing support throughout your treatment journey. If you experience side effects requiring dose adjustment or management strategies, you can contact our pharmacists for advice without additional consultation fees. We coordinate with your NHS GP when appropriate, ensuring continuity of care between private weight loss treatment and your broader healthcare. Discreet packaging and next-day delivery options support treatment adherence whilst maintaining privacy.

Starting Your Mounjaro Journey Safely

Begin with realistic expectations about side effects and weight loss timelines. Most patients experience some gastrointestinal symptoms during the first month, but these typically improve significantly as your body adapts. The graduated dosing schedule—starting at 2.5mg weekly and increasing every 4 weeks—is specifically designed to minimise side effect severity whilst building therapeutic effect. Patience during this titration phase, combined with evidence-based symptom management strategies, supports successful long-term outcomes with Mounjaro therapy.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., ... & Dex, T. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
  3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14881 [accessed 13 August 2026]
  4. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Side effect frequencies and severity can vary between individuals. If you experience any concerning symptoms whilst taking Mounjaro, contact your prescriber or seek immediate medical attention as appropriate.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What are the most common mounjaro uk nhs side effects?
The most common Mounjaro side effects are gastrointestinal: nausea (20-30% of patients), diarrhoea (15-23%), and vomiting (8-13%), typically mild to moderate and improving within 4-8 weeks. These rates align with NHS England guidance on GLP-1 receptor agonist safety profiles.
How long do Mounjaro side effects last?
Most gastrointestinal side effects peak during dose escalation and improve significantly within 4-8 weeks as your body adapts to tirzepatide. Fewer than 5% of patients experience persistent nausea beyond 6 months of stable-dose therapy, according to extended SURPASS trial data.
Can I reduce Mounjaro side effects without stopping treatment?
Yes—eating smaller frequent meals, avoiding high-fat foods for 48 hours post-injection, maintaining hydration, and timing your injection in the evening can significantly reduce symptom severity. Your prescriber may also recommend staying at your current dose longer before escalating if side effects are troublesome.
What are the serious side effects of Mounjaro I should watch for?
Seek immediate medical attention for severe persistent abdominal pain radiating to your back (potential pancreatitis), repeated vomiting lasting over 24 hours, signs of severe dehydration, sudden upper right abdominal pain (gallbladder issues), or symptoms of allergic reaction including facial swelling or difficulty breathing.
Are Mounjaro side effects worse than Wegovy or Saxenda?
Mounjaro's side effect profile is similar to other GLP-1 treatments, with comparable nausea rates to Wegovy (20-44% in STEP trials) and Saxenda (18-39%). The dual GIP/GLP-1 mechanism may offer tolerability advantages for some patients, though individual responses vary significantly.
Does Mounjaro cause hypoglycaemia (low blood sugar)?
Hypoglycaemia is uncommon with Mounjaro alone but increases if you're also taking insulin or sulfonylureas. The MHRA recommends regular blood glucose monitoring for patients on combination therapy, with dose adjustments to concurrent diabetes medications as needed.
Will I experience nausea every week on Mounjaro?
No—whilst nausea is common initially, it typically occurs most frequently during the first few injections and dose increases, then diminishes substantially. Over 90% of patients who experienced nausea reported improvement within 4-8 weeks of stable dosing.
Do I need ongoing monitoring for Mounjaro side effects?
Yes—NHS guidance recommends baseline renal function testing with repeat assessment if you develop persistent vomiting or diarrhoea. Your prescriber should review treatment efficacy and tolerability at 3-6 month intervals to ensure continued therapy remains clinically appropriate.
Are Mounjaro side effects the same on the NHS and private prescriptions?
Yes, Mounjaro side effects are identical whether prescribed via the NHS or privately through Cured Pharmacy, as the medication formulation is the same. The difference lies in access and cost, with private prescriptions often offering faster availability and lower prices starting from £124.99.
How do Mounjaro UK NHS side effects compare to other weight loss medications?
Mounjaro side effects are similar to other GLP-1 medications like Wegovy and Saxenda, with nausea, diarrhoea, and constipation being most common. However, many patients at Cured Pharmacy report better tolerability with Mounjaro due to its dual-action mechanism and gradual dose escalation protocol.
Can I get NHS advice about Mounjaro side effects when buying privately?
While purchasing Mounjaro privately from Cured Pharmacy, you still have full access to NHS GP services for side effect management and general health concerns. Our UK-registered prescribers also provide ongoing support and guidance on managing any side effects throughout your treatment journey.
Do Mounjaro side effects reduce as you increase the dose from £124.99 starter packs?
Most Mounjaro side effects are strongest during the initial 2.5mg dose and typically decrease as your body adjusts, even when escalating to higher doses. Cured Pharmacy's prescribers carefully manage your dose progression to minimise side effects while maximising weight loss results.
What should I do if Mounjaro side effects become severe after starting treatment?
If you experience severe side effects with Mounjaro, contact Cured Pharmacy's clinical team immediately for personalised advice on dose adjustment or symptom management. You should also consult your NHS GP or seek emergency care if symptoms include persistent vomiting, severe abdominal pain, or signs of pancreatitis.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.